1. Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus
- Author
-
Philip R. Schauer, Esam Batayyah, Jennifer Mackey, Tomasz Rogula, Matthew Kroh, Laurence Kennedy, John P. Kirwan, Héctor Romero-Talamás, Sangeeta R. Kashyap, Ali Aminian, Stacy A. Brethauer, and Bipan Chand
- Subjects
Adult ,Male ,medicine.medical_specialty ,Sleeve gastrectomy ,medicine.medical_treatment ,Bariatric Surgery ,Type 2 diabetes ,Article ,Nephropathy ,Recurrence ,Risk Factors ,Diabetes mellitus ,Humans ,Medicine ,Obesity ,Aged ,Retrospective Studies ,business.industry ,Type 2 Diabetes Mellitus ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Surgery ,Logistic Models ,Treatment Outcome ,Diabetes Mellitus, Type 2 ,ROC Curve ,Metabolic effects ,Multivariate Analysis ,Female ,business ,Biomarkers ,Follow-Up Studies - Abstract
Evaluate the long-term effects of bariatric surgery on type 2 diabetes (T2DM) remission and metabolic risk factors.Although the impressive antidiabetic effects of bariatric surgery have been shown in short- and medium-term studies, the durability of these effects is uncertain. Specifically, long-term remission rates following bariatric surgery are largely unknown.Clinical outcomes of 217 patients with T2DM who underwent bariatric surgery between 2004 and 2007 and had at least 5-year follow-up were assessed. Complete remission was defined as glycated hemoglobin (A1C) less than 6% and fasting blood glucose (FBG) less than 100 mg/dL off diabetic medications. Changes in other metabolic comorbidities, including hypertension, dyslipidemia, and diabetic nephropathy, were assessed.At a median follow-up of 6 years (range: 5-9) after surgery (Roux-en-Y gastric bypass, n = 162; gastric banding, n = 32; sleeve gastrectomy, n = 23), a mean excess weight loss (EWL) of 55% was associated with mean reductions in A1C from 7.5% ± 1.5% to 6.5% ± 1.2% (P0.001) and FBG from 155.9 ± 59.5 mg/dL to 114.8 ± 40.2 mg/dL (P0.001). Long-term complete and partial remission rates were 24% and 26%, respectively, whereas 34% improved (1% decrease in A1C without remission) from baseline and 16% remained unchanged. Shorter duration of T2DM (P0.001) and higher long-term EWL (P = 0.006) predicted long-term remission. Recurrence of T2DM after initial remission occurred in 19% and was associated with longer duration of T2DM (P = 0.03), less EWL (P = 0.02), and weight regain (P = 0.015). Long-term control rates of low high-density lipoprotein, high low-density lipoprotein, high triglyceridemia, and hypertension were 73%, 72%, 80%, and 62%, respectively. Diabetic nephropathy regressed (53%) or stabilized (47%).Bariatric surgery can induce a significant and sustainable remission and improvement of T2DM and other metabolic risk factors in severely obese patients. Surgical intervention within 5 years of diagnosis is associated with a high rate of long-term remission.
- Published
- 2013